Anti-arrhythmic Drugs (AADs) ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 84 | サルコイドーシス | 1 |
84. サルコイドーシス
臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05524077 (ClinicalTrials.gov) | July 8, 2020 | 24/8/2022 | Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia | Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia (CAAD-VT): A Randomised Trial | Heart Disease Structural Disorder;Ventricular Tachycardia;Cardiomyopathy, Dilated;Sarcoidosis;Cardiomyopathy, Hypertrophic;Cardiomyopathy Ischemic;Cardiomyopathy, Familial;Arrhythmogenic Right Ventricular Cardiomyopathy 1;Arrhythmogenic Left Ventricular Cardiomyopathy | Procedure: Ablation;Drug: Anti-arrhythmic Drugs (AADs) | Western Sydney Local Health District | NULL | Recruiting | 18 Years | N/A | All | 162 | N/A | Australia |